Lineage Cell Therapeutics Inc (AMEX:LCTX) traded at $0.59 at close of the session on Friday, January 03 and made an upward move of 14.58% on its previous day’s price.
Looking at the stock we see that its previous close was $0.51 and the beta (5Y monthly) reads 1.282 with the day’s price range being $0.5015 – $0.5901. In terms of its 52-week price range, LCTX has a high of $1.61 and a low of $0.48. The company’s stock has gained about 7.92% over that past 30 days.
Lineage Cell Therapeutics Inc has a market cap of $149.04 million and is expected to release its quarterly earnings report in February.
On the other hand, looking at the outlook for the LCTX stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell.
Looking further, we note the current price level is 9.76% off its SMA20 and -13.42% from its 50-day simple moving average. The RSI (14) is pointing at 52.42 while the volatility over the past week is 8.64% and jumps to 8.93% over the past one month. The beta value is 1.19, while the average true range (ATR) is currently pointing at 0.05.
Coming back to Lineage Cell Therapeutics Inc (AMEX:LCTX), we note that the average 3-month trading volume was 2.06 million, while that of the preceding 10-day period stands at 3.4 million. Current shares outstanding are 220.42 million.
The insiders hold 0.66% of the company’s shares while institutions hold 43.58%. The data shows that short shares as of 2024-10-31, stood at 15.94 million at a short ratio of 35.21. This represents a 1089.00 short interest in shares outstanding on 2024-10-31. Shares short rose in October from the previous month at 15.22 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 17.43% up in year-to-date price movement.
